×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
BMY – bristol-myers squibb company (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BMY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
12:18 am
bmy
Top Growth Stocks With Insider Backing In December 2024 [Yahoo! Finance]
Low
Report
Top Growth Stocks With Insider Backing In December 2024 [Yahoo! Finance]
12/19
07:11 pm
bmy
Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today [Yahoo! Finance]
Low
Report
Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today [Yahoo! Finance]
12/19
10:12 am
bmy
3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income [Yahoo! Finance]
Low
Report
3 High-Yielding Dividend Stocks That Retirees Can Rely On for Recurring Income [Yahoo! Finance]
12/19
08:44 am
bmy
Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive Officer [Yahoo! Finance]
Low
Report
Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive Officer [Yahoo! Finance]
12/19
08:07 am
bmy
Is SPDR Russell 1000 Yield Focus ETF (ONEY) a Strong ETF Right Now? [Yahoo! Finance]
Low
Report
Is SPDR Russell 1000 Yield Focus ETF (ONEY) a Strong ETF Right Now? [Yahoo! Finance]
12/19
06:59 am
bmy
Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
Low
Report
Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025
12/19
06:31 am
bmy
Got $250? 2 Healthcare Stocks to Buy and Hold Forever [Yahoo! Finance]
Low
Report
Got $250? 2 Healthcare Stocks to Buy and Hold Forever [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
10/31/2024
06:59 am
bmy
bristol-myers squibb company
BEAT
Report
5.1%
bristol-myers squibb company
7/26/2024
06:59 am
bmy
bristol-myers squibb company
BEAT
Report
10.8%
bristol-myers squibb company
4/25/2024
06:59 am
bmy
bristol-myers squibb company
MISS
Report
-9.4%
bristol-myers squibb company
2/2/2024
06:59 am
bmy
bristol-myers squibb company
BEAT
Report
-0.1%
bristol-myers squibb company
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/13
04:17 pm
bmy
Form S-3ASR BRISTOL MYERS SQUIBB CO
Low
Report
Form S-3ASR BRISTOL MYERS SQUIBB CO
11/5
05:53 pm
bmy
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 04 Filed by: Holzer Phil M
Low
Report
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 04 Filed by: Holzer Phil M
11/5
05:51 pm
bmy
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 01 Filed by: Shanahan Karin
Low
Report
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 01 Filed by: Shanahan Karin
11/5
05:48 pm
bmy
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 01 Filed by: Meyers Gregory Scott
Low
Report
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 01 Filed by: Meyers Gregory Scott
11/5
05:43 pm
bmy
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 01 Filed by: BOERNER CHRISTOPHER S.
Low
Report
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 01 Filed by: BOERNER CHRISTOPHER S.
11/5
05:41 pm
bmy
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 01 Filed by: Hirawat Samit
Low
Report
Form 4 BRISTOL MYERS SQUIBB CO For: Nov 01 Filed by: Hirawat Samit
11/4
11:21 am
bmy
Form 144 BRISTOL MYERS SQUIBB CO Filed by: Holzer Phil M
Low
Report
Form 144 BRISTOL MYERS SQUIBB CO Filed by: Holzer Phil M
10/31
11:45 am
bmy
Form 10-Q BRISTOL MYERS SQUIBB CO For: Sep 30
Low
Report
Form 10-Q BRISTOL MYERS SQUIBB CO For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
7/24
Bristol-Myers releases mixed Opdivo lung cancer results [Reuters]
10.2%
3/12 Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: LEUNG SANDRA 7.9%
3/25 Form DEF 14A BRISTOL MYERS SQUIBB CO For: May 05 5.9%
4/8 Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combined with Limited Chemotherapy in First-Line Lung Cancer 4.3%
3/3 Voluntis and Bristol-Myers Squibb to Co-Develop Digital Therapeutics for Oncology 3.9%
4/3 Form 3 BRISTOL MYERS SQUIBB CO For: Mar 30 Filed by: Mily Elizabeth 3.4%
8/25 Better Buy: Biogen vs. Celgene [The Motley Fool] 3.1%
3/31 Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121) to FDA 2.8%
4/20 Bristol Myers Squibb Announces Positive Topline Result from Pivotal Phase 3 Trial Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) vs. Chemotherapy in Previously Untreated Malignant Pleural Mesothelioma 2.8%
8/15 What Has Led Bristol-Myers Squibb's Stock To Fall More Than 35% Over The Last 3 Years? [Forbes] 2.7%
3/12 Form 4 BRISTOL MYERS SQUIBB CO For: Mar 10 Filed by: LEUNG SANDRA 7.9%
3/25 Form DEF 14A BRISTOL MYERS SQUIBB CO For: May 05 5.9%
4/8 Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combined with Limited Chemotherapy in First-Line Lung Cancer 4.3%
3/3 Voluntis and Bristol-Myers Squibb to Co-Develop Digital Therapeutics for Oncology 3.9%
4/3 Form 3 BRISTOL MYERS SQUIBB CO For: Mar 30 Filed by: Mily Elizabeth 3.4%
8/25 Better Buy: Biogen vs. Celgene [The Motley Fool] 3.1%
3/31 Bristol Myers Squibb and bluebird bio Announce Submission of Biologics License Application (BLA) for Anti-BCMA CAR T Cell Therapy Idecabtagene Vicleucel (Ide-cel, bb2121) to FDA 2.8%
4/20 Bristol Myers Squibb Announces Positive Topline Result from Pivotal Phase 3 Trial Evaluating Opdivo® (nivolumab) plus Yervoy® (ipilimumab) vs. Chemotherapy in Previously Untreated Malignant Pleural Mesothelioma 2.8%
8/15 What Has Led Bristol-Myers Squibb's Stock To Fall More Than 35% Over The Last 3 Years? [Forbes] 2.7%
TOP News Decliners
6/24
Bristol-Myers Squibb Announces Results from CheckMate -459 Study Evaluating Opdivo (nivolumab) as a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma
-7.8%
3/11 Nationwide class actions are safe, thanks to the D.C. and 7th Circuits [Reuters] -7.1%
10/22 Bristol-Myers' immunotherapies show promise in lung cancer trial; shares rise [Yahoo! Finance News] -4.9%
3/6 Form 4 BRISTOL MYERS SQUIBB CO For: Mar 04 Filed by: Elicker John E -4.4%
3/20 Bristol-Myers Squibb, Sanofi strike out in bid to stop Plavix litigation [Seeking Alpha] -4.3%
3/18 Bristol Myers Squibb Appoints Elizabeth Mily as Executive Vice President, Strategy & Business Development -4.3%
2/26 Form 4 BRISTOL MYERS SQUIBB CO For: Feb 03 Filed by: Metcalfe Kathryn -4.0%
3/16 BMY Stock Dives As Investors Worry Coronavirus Could Delay A Key Drug [Investor's Business Daily] -3.6%
4/7 Bristol Myers Squibb Expands Patient Support Programs to Help Newly Uninsured Patients in the U.S. -3.6%
4/20 Bristol Myers Squibb's Cancer Drug Opdivo Successful in 2 Clinical Trials [The Motley Fool] -3.5%
3/11 Nationwide class actions are safe, thanks to the D.C. and 7th Circuits [Reuters] -7.1%
10/22 Bristol-Myers' immunotherapies show promise in lung cancer trial; shares rise [Yahoo! Finance News] -4.9%
3/6 Form 4 BRISTOL MYERS SQUIBB CO For: Mar 04 Filed by: Elicker John E -4.4%
3/20 Bristol-Myers Squibb, Sanofi strike out in bid to stop Plavix litigation [Seeking Alpha] -4.3%
3/18 Bristol Myers Squibb Appoints Elizabeth Mily as Executive Vice President, Strategy & Business Development -4.3%
2/26 Form 4 BRISTOL MYERS SQUIBB CO For: Feb 03 Filed by: Metcalfe Kathryn -4.0%
3/16 BMY Stock Dives As Investors Worry Coronavirus Could Delay A Key Drug [Investor's Business Daily] -3.6%
4/7 Bristol Myers Squibb Expands Patient Support Programs to Help Newly Uninsured Patients in the U.S. -3.6%
4/20 Bristol Myers Squibb's Cancer Drug Opdivo Successful in 2 Clinical Trials [The Motley Fool] -3.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: